Genotoxicity testing of potassium canrenoate in cultured rat and human cells

Mutagenesis

Volumn 14, Issue 5, 1999, Pages 463-472

  Martelli, Antonietta ^a   Mattioli, Francesca ^a   Carrozzino, Roberto ^a   Ferraris, Eleonora ^a   Marchese, Monica ^a   Angiola, Marianna ^a   Brambilla, Giovanni ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANRENOATE POTASSIUM; DIURETIC AGENT; DNA FRAGMENT;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DNA DEGRADATION; DNA REPAIR; GENOTOXICITY; HUMAN; HUMAN CELL; LIVER CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING;

ADULT; AGED; ALDOSTERONE ANTAGONISTS; ANIMALS; CANRENOATE POTASSIUM; CELL SURVIVAL; CELLS, CULTURED; DNA; DNA DAMAGE; DNA FRAGMENTATION; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIVER; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032825365     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/14.5.463     Document Type: Article

References (22)

1. Bailey, N.T.J. (1959) Statistical Methods in Biology. English Universities Press, London, UK.
2. Brambilla, G., Robbiano, L., Martelli, A., Cajelli, E., Allavena, A. and Mazzei, M. (1989) Genotoxicity of N-nitrosochlordiazepoxide in cultured mammalian cells. Toxicol. Appl. Pharmacol., 97, 480-488.
3. Cook, C.S., Hauswald, C.L., Schoenhard, G.L., Piper, C.E., Patel, A., Radzialowski, F.M., Hribar, J.D., Aksamit, W., Finnegan, P., Bible, R.H. and Oppermann, J.A. (1988) Difference in metabolic profile of potassium canrenoate and spironolactone in the rat: mutagenic metabolites unique to potassium canrenoate. Arch. Toxicol., 61, 201-212.
4. Cook, C.S., Hauswald, C., Oppermann, J.A. and Schoenhard, G.L. (1993) Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite. J. Pharmacol. Exp. Ther., 266, 1-7.
5. Feser, W., Kerdar, R.S., Baumann, A., Körber, J., Blode, H. and Kuhnz, W. (1998) DNA adduct formation of selected sex steroids in human liver slices in vitro. Toxicol. In Vitro, 12, 353-364.
6. Hwang, J.J., Hsia, M.T.S. and Jirtle, R.L. (1993) Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator, Wy-14,643. Mutat. Res., 286, 123-133.
7. Kerdar, R.S., Baumann, A., Brudny-Klöppel, M., Biere, H., Blode, H. and Kuhnz, W. (1995) Identification of 3a-hydroxy-cyproterone acetate as a metabolite of cyproterone acetate in the bile of female rats and the potential of this and other already known or putative metabolites to form DNA adducts in vitro. Carcinogenesis, 16, 1835-1841.
8. Madle, S., Dean, S.W., Andrae, U., Brambilla, G., Burlinson, B., Doolittle, D.J., Furihata, C., Hertner, T., McQueen, C.A. and Mori, H. (1994) Recommendations for the performance of UDS tests in vitro and in vivo. Mutat. Res., 312, 263-285.
9. Martelli, A. (1995) Primary human and rat hepatocytes in genotoxicity assessment. Anticancer Res., 15, 1741.
10. Martelli, A., Mattioli, F., Fazio, S., Andrae, U. and Brambilla, G. (1995) DNA repair synthesis and DNA fragmentation in primary cultures of human and rat hepatocytes exposed to cyproterone acetate. Carcinogenesis, 16, 1265-1269.
11. Martelli, A., Mattioli, F., Ghia, M., Mereto, E. and Brambilla, G. (1996a) Comparative study of DNA repair induced by cyproterone acetate, chlormadinone acetate and megestrol acetate in primary cultures of human and rat hepatocytes. Carcinogenesis, 17, 1153-1156.
12. Martelli, A., Brambilla Campart, G., Ghia, M., Allavena, A., Mereto, E. and Brambilla, G. (1996b) Induction of micronuclei and initiation of enzymealtered foci in the liver of female rats treated with cyproterone acetate, chlormadinone acetate or megestrol acetate. Carcinogenesis, 17, 551-554.
13. Ramsay, L., Shelton, J., Harrison, I., Tidd, M. and Asbury, M. (1976) Spironolactone and potassium canreonate in normal man. Clin. Pharmacol. Ther., 20, 167-177.
14. Regan, J.D. and Setlow, R.B. (1974) Two forms of repair in the DNA of human cells damaged by chemical carcinogens and mutagens. Cancer Res., 34, 3318-3325.
15. Rojas, E., Valverde, M., Sordo, M. and Ostrosky-Wegman, P. (1996) DNA damage in exfoliated buccal cells of smokers assessed by the single cell gel electrophoresis assay. Mutat. Res., 370, 111-120.
16. Singh, N.P., McCoy, M.T., Tice, R.R. and Schneider, E.L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191.
17. Strom, S.C., Jirtle, R.L., Jones, R.S., Novicki, D.L., Rosenberg, M.R., Novotny, A., Irons, G., McLain, J.R. and Michalopoulos, G. (1982) Isolation, culture, and transplantation of human hepatocytes. J. Natl Cancer Inst., 68, 771-778.
18. Topinka, J., Andrae, U., Schwarz, L.R. and Wolff, T. (1993) Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocytes cultures. Carcinogenesis, 14, 423-427.
19. Topinka, J., Binkova, B., Zhu, H.K., Andrae, U., Neumann, I., Schwarz, L.R., Werner, S. and Wolff, T. (1995) DNA damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver. Carcinogenesis, 16, 1483-1487.
20. Werner, S., Kunz, S., Wolff, T. and Schwarz, L.R. (1996) Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation. Cancer. Res., 56, 4391-4397.
21. Werner, S., Kunz, S., Beckurts, T., Heidecke, C.D., Wolff, T. and Schwarz, L.R. (1997) Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes. Mutat. Res., 395, 179-187.
22. Williams, G.M. (1977) Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Res., 37, 1845-1851.